C47H51NO14
853.9 g/mol
APIDanger
Paclitaxel
CAS33069-62-4
Category
API
Compound Class
Natural Product
Primary Use
Pharmaceutical Raw Material
Paclitaxel is a complex diterpenoid compound used as an active pharmaceutical ingredient. It is primarily employed in pharmaceutical manufacturing and research, particularly for studies involving microtubule structure and function.
tool in the study of microtubule structure and functionactive pharmaceutical ingredient for oncological researchresearch compound for antiplatelet studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 33069-62-4
Related Compounds
StrongStructure SimilarSimilarity 0.89
10-deacetylpaclitaxel
CAS78432-77-6
pharmaceutical raw material
StrongStructure SimilarSimilarity 0.87
Cephalomannine
CAS71610-00-9
pharmaceutical raw material
StrongStructure SimilarSimilarity 0.86
Docetaxel
CAS125354-16-7
active pharmaceutical ingredient
ReferenceSame Category
Avanafil
CAS330784-47-9
pharmaceutical raw material
ReferenceSame Category
Vardenafil hydrochloride trihydrate
CAS330808-88-3
pharmaceutical raw material
ReferenceSame Category
Amitraz
CAS33089-61-1
pharmaceutical raw material
ReferenceSame Category
Humanin
CAS330936-69-1
pharmaceutical raw material
Referencestereoisomer of
Paclitaxel D5
CAS1129540-33-5
pharmaceutical raw material
Safety Reference
Danger
H315Causes skin irritation
H317May cause an allergic skin reaction
H318Causes serious eye damage
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335May cause respiratory irritation
H340May cause genetic defects
H341Suspected of causing genetic defects
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
H413May cause long lasting harmful effects to aquatic life
Identifiers
IUPAC Name
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
InChIKey
RCINICONZNJXQF-MZXODVADSA-N
SMILES
CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
Synonyms (111)
- LEP-ETU
- TAXOL
- Paclitaxel (JAN/USP/INN)
- Paclitaxel natural for peak identification, European Pharmacopoeia (EP)
- Paclitaxel semi-synthetic for peak identification, European Pharmacopoeia (EP)
- Paclitaxel semi-synthetic for system suitability, European Pharmacopoeia (EP)
- Paclitaxel, European Pharmacopoeia (EP)
- Paclitaxel, United States Pharmacopeia (USP)
- Paclitaxel; Docetaxel EP Impurity F
- 7 epi Taxol
- ABI-007 COMPONENT PACLITAXEL
- ABRAXANE COMPONENT PACLITAXEL
- Abraxane
- Abraxane (TN)
- Abraxane I.V. Suspension
- Anzatax
- BMS 181339-01
- Bris Taxol
- Capxol
- Coroflex Please
- Cyclopax
- Cynviloq
- Cypher select
- Ebetaxel
- EmPAC
- EndoTAG 1
- Genaxol
- Genetaxyl
- Genexol
- Genexol-PM
- Infinnium
- Intaxel
- LipoPac
- Mitotax
- Nanotaxel
- Nanoxel
- ORAXOL COMPONENT PACLITAXEL
- OncoGel
- Onxal
- Onxol
- P-SSMM-VIP
- PACLITAXEL PACLITAXEL
- PACLITAXEL [MART.]
- Paclical
- Pacliex
- Pacligel
- Paclitaxel (Standard)
- Paclitaxel (Taxol)
- Paclitaxel (natural)
- Paclitaxel (taxus canadensis)
- Paclitaxel CRS
- Paclitaxel HCL
- Paclitaxel, Taxus brevifolia
- Paclitaxel, semi-synthetic
- Paclitaxel-SSMM-VIP
- Paclitaxol
- Padexol
- Paxceed
- Paxene
- Paxoral
- Plaxicel
- Sindaxel
- TAXOL (TN)
- TaxAlbin
- Taxol (Paclitaxel)
- Taxol (TN) (Bristol Meyers)
- Taxol 100
- Taxol A
- Taxol, Bris
- Taxus
- Taxus Express
- Taxus Liberte
- Taxus stent
- Tocosol Paclitaxel
- Xorane
- Yewtaxan
- Zisu
- l diacetate
- nab-paclitaxel
- paclitaxel
- paclitaxelum